414 related articles for article (PubMed ID: 20201550)
1. Tumor targeting chitosan nanoparticles for dual-modality optical/MR cancer imaging.
Nam T; Park S; Lee SY; Park K; Choi K; Song IC; Han MH; Leary JJ; Yuk SA; Kwon IC; Kim K; Jeong SY
Bioconjug Chem; 2010 Apr; 21(4):578-82. PubMed ID: 20201550
[TBL] [Abstract][Full Text] [Related]
2. Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles.
Park K; Kim JH; Nam YS; Lee S; Nam HY; Kim K; Park JH; Kim IS; Choi K; Kim SY; Kwon IC
J Control Release; 2007 Oct; 122(3):305-14. PubMed ID: 17643545
[TBL] [Abstract][Full Text] [Related]
3. Effect of the stability and deformability of self-assembled glycol chitosan nanoparticles on tumor-targeting efficiency.
Na JH; Lee SY; Lee S; Koo H; Min KH; Jeong SY; Yuk SH; Kim K; Kwon IC
J Control Release; 2012 Oct; 163(1):2-9. PubMed ID: 22846988
[TBL] [Abstract][Full Text] [Related]
4. Oleyl-chitosan nanoparticles based on a dual probe for optical/MR imaging in vivo.
Lee CM; Jang D; Kim J; Cheong SJ; Kim EM; Jeong MH; Kim SH; Kim DW; Lim ST; Sohn MH; Jeong YY; Jeong HJ
Bioconjug Chem; 2011 Feb; 22(2):186-92. PubMed ID: 21243999
[TBL] [Abstract][Full Text] [Related]
5. Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice.
Huh MS; Lee SY; Park S; Lee S; Chung H; Lee S; Choi Y; Oh YK; Park JH; Jeong SY; Choi K; Kim K; Kwon IC
J Control Release; 2010 Jun; 144(2):134-43. PubMed ID: 20184928
[TBL] [Abstract][Full Text] [Related]
6. In vivo MR/optical imaging for gastrin releasing peptide receptor of prostate cancer tumor using Gd-TTDA-NP-BN-Cy5.5.
Lin YH; Dayananda K; Chen CY; Liu GC; Luo TY; Hsu HS; Wang YM
Bioorg Med Chem; 2011 Feb; 19(3):1085-96. PubMed ID: 20493715
[TBL] [Abstract][Full Text] [Related]
7. Hydrotropic oligomer-conjugated glycol chitosan as a carrier of paclitaxel: synthesis, characterization, and in vivo biodistribution.
Saravanakumar G; Min KH; Min DS; Kim AY; Lee CM; Cho YW; Lee SC; Kim K; Jeong SY; Park K; Park JH; Kwon IC
J Control Release; 2009 Dec; 140(3):210-7. PubMed ID: 19560497
[TBL] [Abstract][Full Text] [Related]
8. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
[TBL] [Abstract][Full Text] [Related]
9. T1-Weighted MR imaging of liver tumor by gadolinium-encapsulated glycol chitosan nanoparticles without non-specific toxicity in normal tissues.
Na JH; Lee S; Koo H; Han H; Lee KE; Han SJ; Choi SH; Kim H; Lee S; Kwon IC; Choi K; Kim K
Nanoscale; 2016 May; 8(18):9736-45. PubMed ID: 27113247
[TBL] [Abstract][Full Text] [Related]
10. A new atherosclerotic lesion probe based on hydrophobically modified chitosan nanoparticles functionalized by the atherosclerotic plaque targeted peptides.
Park K; Hong HY; Moon HJ; Lee BH; Kim IS; Kwon IC; Rhee K
J Control Release; 2008 Jun; 128(3):217-23. PubMed ID: 18457896
[TBL] [Abstract][Full Text] [Related]
11. Real-time and non-invasive optical imaging of tumor-targeting glycol chitosan nanoparticles in various tumor models.
Na JH; Koo H; Lee S; Min KH; Park K; Yoo H; Lee SH; Park JH; Kwon IC; Jeong SY; Kim K
Biomaterials; 2011 Aug; 32(22):5252-61. PubMed ID: 21513975
[TBL] [Abstract][Full Text] [Related]
12. Tumor-homing photosensitizer-conjugated glycol chitosan nanoparticles for synchronous photodynamic imaging and therapy based on cellular on/off system.
Lee SJ; Koo H; Lee DE; Min S; Lee S; Chen X; Choi Y; Leary JF; Park K; Jeong SY; Kwon IC; Kim K; Choi K
Biomaterials; 2011 Jun; 32(16):4021-9. PubMed ID: 21376388
[TBL] [Abstract][Full Text] [Related]
13. In vivo NIRF and MR dual-modality imaging using glycol chitosan nanoparticles.
Key J; Cooper C; Kim AY; Dhawan D; Knapp DW; Kim K; Park JH; Choi K; Kwon IC; Park K; Leary JF
J Control Release; 2012 Oct; 163(2):249-55. PubMed ID: 22902594
[TBL] [Abstract][Full Text] [Related]
14. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
15. Tumor-homing multifunctional nanoparticles for cancer theragnosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoring.
Kim K; Kim JH; Park H; Kim YS; Park K; Nam H; Lee S; Park JH; Park RW; Kim IS; Choi K; Kim SY; Park K; Kwon IC
J Control Release; 2010 Sep; 146(2):219-27. PubMed ID: 20403397
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronic acid-ceramide-based optical/MR dual imaging nanoprobe for cancer diagnosis.
Cho HJ; Yoon HY; Koo H; Ko SH; Shim JS; Cho JH; Park JH; Kim K; Kwon IC; Kim DD
J Control Release; 2012 Aug; 162(1):111-8. PubMed ID: 22709587
[TBL] [Abstract][Full Text] [Related]
17. Self-assembled magnetic resonance imaging nanoprobes based on arachidyl chitosan for cancer diagnosis.
Termsarasab U; Cho HJ; Moon HT; Park JH; Yoon IS; Kim DD
Colloids Surf B Biointerfaces; 2013 Sep; 109():280-6. PubMed ID: 23665478
[TBL] [Abstract][Full Text] [Related]
18. Electrostatically assembled biocompatible polymer nanoparticles for MR/optical dual-modality imaging nanoprobes.
Chung KH; Cho MY; Sung MH; Poo H; Lim YT
Chem Commun (Camb); 2011 Aug; 47(31):8889-91. PubMed ID: 21748163
[TBL] [Abstract][Full Text] [Related]
19. Upconverting rare-earth nanoparticles with a paramagnetic lanthanide complex shell for upconversion fluorescent and magnetic resonance dual-modality imaging.
Wang Y; Ji L; Zhang B; Yin P; Qiu Y; Song D; Zhou J; Li Q
Nanotechnology; 2013 May; 24(17):175101. PubMed ID: 23558298
[TBL] [Abstract][Full Text] [Related]
20. Gadolinium-chitosan nanoparticles as a novel contrast agent for potential use in clinical bowel-targeted MRI: a feasibility study in healthy rats.
Cheng JJ; Zhu J; Liu XS; He DN; Xu JR; Wu LM; Zhou J; Feng Q
Acta Radiol; 2012 Oct; 53(8):900-7. PubMed ID: 22919051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
